EGFR and astrocytic tumor: The majority of tumors exhibited the 1p/19q-co-deletion (82%), while a minority of cases (18%) harbored molecular alterations frequently observed in high-grade astrocytic tumors (i.e., EGFR amplification, chromosome 10 loss).